Avantor (NYSE:AVTR) PT Raised to $25.00

Avantor (NYSE:AVTR) had its target price upped by research analysts at Deutsche Bank Aktiengesellschaft from $23.00 to $25.00 in a research report issued on Thursday, Benzinga reports. The firm currently has a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft’s price objective would suggest a potential upside of 3.73% from the company’s previous close.

Several other analysts have also recently issued reports on the stock. UBS Group upped their target price on shares of Avantor from $25.00 to $29.00 and gave the company a “buy” rating in a research report on Thursday, February 15th. Robert W. Baird increased their price objective on shares of Avantor from $25.00 to $26.00 and gave the stock an “outperform” rating in a research report on Thursday, February 15th. Citigroup increased their price objective on shares of Avantor from $24.00 to $30.00 and gave the stock a “buy” rating in a research report on Thursday, February 15th. Evercore ISI increased their price objective on shares of Avantor from $26.00 to $28.00 and gave the stock an “outperform” rating in a research report on Thursday, April 4th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Avantor from $26.00 to $29.00 and gave the stock an “overweight” rating in a research report on Thursday, February 15th. Four equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Avantor currently has a consensus rating of “Moderate Buy” and a consensus price target of $26.71.

Avantor Stock Down 0.8 %

Shares of NYSE AVTR opened at $24.10 on Thursday. The firm’s 50-day moving average price is $24.93 and its 200-day moving average price is $22.46. The company has a current ratio of 1.61, a quick ratio of 1.05 and a debt-to-equity ratio of 1.00. The stock has a market capitalization of $16.35 billion, a price-to-earnings ratio of 50.21, a P/E/G ratio of 1.53 and a beta of 1.37. Avantor has a 12-month low of $16.63 and a 12-month high of $26.16.

Avantor (NYSE:AVTR) last announced its earnings results on Wednesday, February 14th. The company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $0.03. The firm had revenue of $1.72 billion for the quarter, compared to analysts’ expectations of $1.70 billion. Avantor had a net margin of 4.61% and a return on equity of 14.11%. The business’s revenue was down 4.0% compared to the same quarter last year. During the same period in the prior year, the company earned $0.32 EPS. On average, equities research analysts anticipate that Avantor will post 1.01 EPS for the current fiscal year.

Insider Transactions at Avantor

In other news, EVP James Bramwell sold 6,203 shares of the firm’s stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $24.49, for a total transaction of $151,911.47. Following the transaction, the executive vice president now directly owns 101,143 shares of the company’s stock, valued at $2,476,992.07. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.50% of the company’s stock.

Hedge Funds Weigh In On Avantor

Hedge funds and other institutional investors have recently modified their holdings of the business. Raymond James & Associates boosted its stake in shares of Avantor by 84.8% during the fourth quarter. Raymond James & Associates now owns 1,165,646 shares of the company’s stock valued at $26,612,000 after purchasing an additional 534,901 shares in the last quarter. DAVENPORT & Co LLC boosted its stake in shares of Avantor by 17.6% during the fourth quarter. DAVENPORT & Co LLC now owns 2,283,767 shares of the company’s stock valued at $52,430,000 after purchasing an additional 342,452 shares in the last quarter. Vaughan Nelson Investment Management L.P. boosted its stake in shares of Avantor by 8.4% during the fourth quarter. Vaughan Nelson Investment Management L.P. now owns 2,508,557 shares of the company’s stock valued at $57,269,000 after purchasing an additional 194,031 shares in the last quarter. Northern Trust Corp boosted its stake in shares of Avantor by 9.0% during the third quarter. Northern Trust Corp now owns 4,129,447 shares of the company’s stock valued at $87,049,000 after purchasing an additional 342,553 shares in the last quarter. Finally, State Board of Administration of Florida Retirement System boosted its stake in shares of Avantor by 12.7% during the third quarter. State Board of Administration of Florida Retirement System now owns 658,563 shares of the company’s stock valued at $13,883,000 after purchasing an additional 74,078 shares in the last quarter. 95.08% of the stock is currently owned by institutional investors.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.